CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes Bridging the Gap Between Epigenetic and Genetic in PAH Stress Echocardiography and PH: What Do the Findings Mean? Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week Risk Stratification in PAH

Original Research2013 Sep 17;62(12):1092-1100.

JOURNAL:J Am Coll Cardiol. Article Link

Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)

Chen SL, Zhang FF, Xu J et al. Keywords: 6-min walk test; 6MWT; CO; IPAH; MPA; N-terminal brain natriuretic peptide; NT-BNP; PA; PADN; PAH; PAOP; PAP; PVR; RA; RV; TPG; Tei; cardiac output; denervation; idiopathic pulmonary arterial hypertension; main pulmonary artery; pulmonary artery; pulmonary artery denervation; pulmonary artery hypertension; pulmonary artery occlusive pressure; pulmonary artery pressure; pulmonary vascular resistance; right atrium/atrial; right ventricle/ventricular; transpulmonary pressure gradient; tricuspid excursion index

Full Text PDF